| Ytd | -68.61% | |
| 1y | 41.56% |
| Open | 9.27 | Prev Close | 9.42 | Low | 8.96 | High | 9.36 | Mkt Cap | 526.74M |
| Vol | 3.26M | Avg Vol | 6.43M | EPS | -2.45 | P/E | N/A | Forward P/E | -35.03 |
| Beta | 0.42 | Short Ratio | 13.95 | Inst. Own | 59.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 9.96 | 200-d Avg | 23.52 | 1yr Est | 53.60 |
CAPR News
New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud v
SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP—a national plainti
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100
NEW ORLEANS, Sept. 18, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, rem
SAN DIEGO, Sept. 18, 2026 /PRNewswire/ -- Robbins LLP informs investors that a securities class acti
San Diego, California--(Newsfile Corp. - September 18, 2026) - Robbins Geller Rudman & Dowd LLP anno
San Francisco, California--(Newsfile Corp. - September 18, 2026) - Hagens Berman Sobol Shapiro LLP-a
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces th
NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
Capricor Therapeutics Investors with Losses on their Investment are Reminded to Contact BFA Law by S
SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP—a national plaintiffs'
New York, New York--(Newsfile Corp. - September 17, 2026) - Kaplan Fox & Kilsheimer LLP announces th
BENSALEM, Pa., Sept. 17, 2026 /PRNewswire/ -- The Law Offices of Howard G.
NEW ORLEANS, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service,
LOS ANGELES, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national sha
A securities class action alleges Capricor Therapeutics did not follow the pre-specified blinding an
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has bee
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
Philadelphia, Pennsylvania--(Newsfile Corp. - September 17, 2026) - National plaintiffs' law firm Be
– Late-Breaking Data to Include HOPE-3 Delayed-Start and Natural History Analyses Submitted in the R
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has
NEW YORK--(BUSINESS WIRE)---- $CAPR #BFA--Capricor Therapeutics Securities Fraud Class Action after
SAN DIEGO, Sept. 16, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announce
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP—a national plainti
New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP announces th
New class action for Capricor (CAPR) urges investors to seek recovery for alleged securities fraud v
Capricor Therapeutics shares collapsed from $19.70 to $4.19 following FDA briefing documents and an
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suf
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti
NEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP
NEW YORK and NEW ORLEANS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Capricor Therapeutics, Inc.
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has
New York, New York--(Newsfile Corp. - September 15, 2026) - Kaplan Fox & Kilsheimer LLP announces th
A securities class action alleges Capricor Therapeutics told investors its Deramiocel application wa
SAN DIEGO, Sept. 15, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit
LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Capricor Therapeutics,
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor
SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP—a national plaintiffs'
Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Dera
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suf
New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP announces th
B. Riley Securities analyst Madison El-Saadi upgrades Capricor Therapeutics (NASDAQ:CAPR) from Ne
LOS ANGELES, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors
SAN FRANCISCO, Sept. 14, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP—a national plaintiffs'
Capricor's Chief Executive Officer and Chief Financial Officer are named as individual defendants in
LOS ANGELES, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national s
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti